Follow
Andrew Balicki
Andrew Balicki
Pathologists' Assistant at Emory University Hospital
Verified email at emoryhealthcare.org
Title
Cited by
Cited by
Year
ECTO-NOX target for the anticancer isoflavene phenoxodiol.
DJ Morré, PJ Chueh, K Yagiz, A Balicki, C Kim, DM Morré
Oncology research 16 (7), 299-312, 2007
652007
tNOX (ENOX1) target for chemosensitization-low-dose responses in the hormetic concentration range
DJ Morre, S Dick, E Bosneaga, A Balicki, LY Wu, N Mcclain, DM Morre
American Journal of Pharmacology and Toxicology 3, 16-26, 2008
122008
The system can't perform the operation now. Try again later.
Articles 1–2